Clinigence Holdings, Inc. reported unaudited impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported goodwill impairment of $408,466,575.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | -9.52% |
|
+51.15% | +2.50% |
Jun. 27 | Nutex Health to Implement 1-for-10 Reverse Stock Split | MT |
Jun. 24 | Nutex Health Inc.(NasdaqCM:NUTX) dropped from S&P Global BMI Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.32% | 83.53B | |
-21.99% | 75.4B | |
+2.32% | 26.73B | |
-5.06% | 18.25B | |
+6.95% | 18.12B | |
+7.69% | 16.51B | |
+76.20% | 14.05B | |
+76.56% | 13.03B | |
-27.89% | 12.67B |
- Stock Market
- Equities
- NUTX Stock
- NUTX Stock
- News Nutex Health Inc.
- Clinigence Holdings, Inc. Reports Unaudited Impairment Charges for the Third Quarter Ended September 30, 2022